The usefulness of methylation signatures in the ctDNA of lung cancer was demonstrated in the serum of 200 patients by identifying hypermethylated promoter regions of tumor suppressor genes (MGMT, CDKN2A, INK4A, RASSF1A, DAPK, and RARB [107]. This evidence concerns the gene MGMT and lung carcinoma.